175 related articles for article (PubMed ID: 29340018)
1. Survival prediction of kidney renal papillary cell carcinoma by comprehensive LncRNA characterization.
Lan H; Zeng J; Chen G; Huang H
Oncotarget; 2017 Dec; 8(67):110811-110829. PubMed ID: 29340018
[TBL] [Abstract][Full Text] [Related]
2. A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma.
Chen B; Dong D; Yao Q; Zou Y; Hu W
Cancer Cell Int; 2021 Oct; 21(1):545. PubMed ID: 34663322
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analyses of Mutation-Derived Long-Chain Noncoding RNA Signatures of Genome Instability in Kidney Renal Papillary Cell Carcinoma.
Li J; Wei S; Zhang Y; Lu S; Zhang X; Wang Q; Yan J; Yang S; Chen L; Liu Y; Huang Z
Front Genet; 2022; 13():874673. PubMed ID: 35547247
[No Abstract] [Full Text] [Related]
4. A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.
Mao X; Qin X; Li L; Zhou J; Zhou M; Li X; Xu Y; Yuan L; Liu QN; Xing H
Gynecol Oncol; 2018 Apr; 149(1):181-187. PubMed ID: 29525275
[TBL] [Abstract][Full Text] [Related]
5. Potential biomarkers for predicting the overall survival outcome of kidney renal papillary cell carcinoma: an analysis of ferroptosis-related LNCRNAs.
Wu Z; Huang X; Cai M; Huang P
BMC Urol; 2022 Sep; 22(1):152. PubMed ID: 36104680
[TBL] [Abstract][Full Text] [Related]
6. Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Kidney Renal Papillary Cell Carcinoma.
He R; Wang L; Li J; Ma L; Wang F; Wang Y
Front Cell Dev Biol; 2020; 8():612924. PubMed ID: 33344459
[TBL] [Abstract][Full Text] [Related]
7. Construction and validation of an autophagy-related long non-coding RNA signature to predict the prognosis of kidney renal papillary cell carcinoma.
Kang Z; Yang J
J Investig Med; 2022 Oct; 70(7):1536-1544. PubMed ID: 35725019
[TBL] [Abstract][Full Text] [Related]
8. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
Sun Z; Jing C; Xiao C; Li T; Wang Y
Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
[TBL] [Abstract][Full Text] [Related]
9. Identification of a universal 6-lncRNA prognostic signature for three pathologic subtypes of renal cell carcinoma.
Zuo S; Wang L; Wen Y; Dai G
J Cell Biochem; 2019 May; 120(5):7375-7385. PubMed ID: 30378181
[TBL] [Abstract][Full Text] [Related]
10. Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma.
Xie T; Liu B; Liu D; Zhou Y; Yang Q; Wang D; Tang M; Liu W
Front Pharmacol; 2022; 13():1103986. PubMed ID: 36618928
[TBL] [Abstract][Full Text] [Related]
11. Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature.
He RQ; Wei QJ; Tang RX; Chen WJ; Yang X; Peng ZG; Hu XH; Ma J; Chen G
Oncotarget; 2017 Oct; 8(46):80336-80347. PubMed ID: 29113307
[TBL] [Abstract][Full Text] [Related]
12. A seven-lncRNA signature for predicting prognosis in breast carcinoma.
Xu M; Chen Z; Lin B; Zhang S; Qu J
Transl Cancer Res; 2021 Sep; 10(9):4033-4046. PubMed ID: 35116701
[TBL] [Abstract][Full Text] [Related]
13. Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.
Fei H; Chen S; Xu C
BMC Cancer; 2021 Apr; 21(1):411. PubMed ID: 33858375
[TBL] [Abstract][Full Text] [Related]
14. A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma.
Shi D; Qu Q; Chang Q; Wang Y; Gui Y; Dong D
Oncotarget; 2017 Aug; 8(35):58699-58708. PubMed ID: 28938589
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal papillary cell carcinoma.
Yao ZY; Xing CQ; Zhang T; Liu YW; Xing XL
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2235-2244. PubMed ID: 33755961
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma.
Liu Y; Cheng X; Xi P; Zhang Z; Sun T; Gong B
BMC Urol; 2023 Apr; 23(1):54. PubMed ID: 37004005
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-Related lncRNA to Predict the Clinical Outcomes and Molecular Characteristics of Kidney Renal Papillary Cell Carcinoma.
Gong Y; Zhang C; Li H; Yu X; Li Y; Liu Z; He R
Curr Issues Mol Biol; 2024 Feb; 46(3):1886-1903. PubMed ID: 38534739
[TBL] [Abstract][Full Text] [Related]
18. Integrated bioinformatics analysis revealing independent prognostic long non-coding RNAs DNAH17-AS1 and RP11-400N13.2 and their potential oncogenic roles in colorectal cancer.
Zhou W; Pan B; Liu L
Oncol Lett; 2019 Oct; 18(4):3705-3715. PubMed ID: 31516583
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of
Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
[No Abstract] [Full Text] [Related]
20. Genetic landscape of long noncoding RNA (lncRNAs) in glioblastoma: identification of complex lncRNA regulatory networks and clinically relevant lncRNAs in glioblastoma.
Paul Y; Thomas S; Patil V; Kumar N; Mondal B; Hegde AS; Arivazhagan A; Santosh V; Mahalingam K; Somasundaram K
Oncotarget; 2018 Jul; 9(51):29548-29564. PubMed ID: 30038703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
